Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares conducted on October 6, 2025, and filed on October 7, 2025. The Company, a foreign private issuer, executed a share repurchase through BNP Paribas SA as part of an existing buyback programme established under a non-discretionary agreement announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific block of share repurchases rather than general financial performance metrics such as revenue or profit.
- Shares Purchased: 340,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,594.00p; highest price paid was 1,624.50p.
- Average Price: Volume-weighted average price paid was 1,614.05p.
- Trading Venues: Purchases were executed across BATE, CHIX, and XLON (London Stock Exchange).
- Treasury Holdings: Following this purchase, the Company holds 249,056,844 ordinary shares in treasury.
- Shares in Issue: 4,066,351,695 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 6.12% of the total voting rights.
Material Changes and Programme Progress
Since the commencement of the current non-discretionary agreement on September 30, 2025, the Company has purchased an aggregate of 1,592,000 ordinary shares. The transaction reported herein represents the latest tranche of this ongoing programme. The filing confirms that the purchased shares are held as Treasury shares and do not carry voting rights.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the Company's 2024 Annual Report on Form 20-F and Q2 2025 Results.
Investor Verification Checklist
- Verify the total number of shares purchased under the current buyback programme (1,592,000 since Sept 30, 2025).
- Confirm the updated treasury share count (249,056,844) and its impact on the denominator for shareholder notification thresholds (4,066,351,695 shares in issue).
- Review the specific trading venues (BATE, CHIX, XLON) and execution prices to assess market impact.
- Check the 6.12% voting rights attribution to treasury shares for compliance with Disclosure Guidance and Transparency Rules (DTR 5.5.1R).